New Blood: Former Novartis Exec Transitions to Rubius Therapeutics
New Red-Blood-Cell-Derived Therapies Are Poised to Launch Rubius into the Spotlight.
Improving Human Health: The Promise of Epigenetics
A New Perspective for Genomic Research from Prof. Shankar Balsubramanian
Translating Innovation into Therapies
Antimicrobial Resistance and Drug Commercialization Were Key Topics at the Recent ON Helix Conference in Cambridge, U.K.
Literature Review: Dielectrophoresis to the Fore
Old Methodology Resurrected to Allow Inexpensive Label-Free Separation of Cell Populations
- Molecular Devices
- 1311 Orleans Drive
- Sunnyvale AL, 94089
- UNITED STATES
Our focus is on helping our customers succeed in their basic life science and drug discovery research efforts. We strive to understand customer workflows in order to deliver products that will improve their productivity and streamline their protocols. Our commitment to innovation is driven by the needs of our customers and the objectives of their research programs.